Prescription Changes After Imaging: The Causation Link Attorneys Overlook

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

When a prescriber changes medications after reviewing MRI, CT, or X-ray results, that change is clinical evidence linking imaging findings to treatment decisions. Learn how pharmacy records document the prescription-imaging connection and strengthen causation arguments in personal injury cases.

A prescription change that occurs within days of diagnostic imaging -- an MRI, CT scan, or X-ray -- is one of the clearest causation links in personal injury medicine. When a prescriber reviews imaging results showing a herniated disc and immediately switches the patient from ibuprofen to gabapentin, that medication change documents the clinical decision-making chain: the imaging revealed a structural finding, and the prescriber responded by prescribing a medication specifically indicated for the condition the imaging identified.

• Prescription changes following imaging establish a direct causation chain: imaging finding leads to clinical decision leads to new medication
• The pharmacy fill date for the new medication, compared against the imaging date, creates an objective timeline that connects structural pathology to pharmacological treatment
• LienScripts tracks every medication change through its platform, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting the clinical rationale behind prescription modifications
• Defense counsel cannot argue that imaging findings are incidental when the treating physician responded to those findings by changing the medication regimen
• This evidence pattern is particularly powerful for neuropathic pain medications started after nerve impingement is identified on MRI

The Imaging-to-Prescription Chain

In clinical practice, diagnostic imaging often triggers medication changes. A patient initially prescribed conservative treatment -- NSAIDs and muscle relaxants -- may undergo an MRI four to six weeks after an accident when symptoms fail to resolve. If that MRI reveals a disc herniation compressing a nerve root, the prescriber will typically add a neuropathic pain agent like gabapentin or pregabalin, escalate the analgesic regimen, or both.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The most powerful causation evidence I see in pharmacy records is the medication pivot after imaging. A patient on naproxen and cyclobenzaprine for six weeks suddenly starts gabapentin 300mg TID the same week as an MRI. That is not a coincidence -- it is a clinician responding to objective findings. The pharmacy record captures the exact date of that clinical decision."

This chain -- accident causes symptoms, symptoms persist, imaging reveals pathology, prescriber changes medication based on imaging -- is the complete causation narrative. Each link is documented: the accident report, the medical records, the imaging report, and the pharmacy fill records.

Why Pharmacy Records Matter More Than Medical Records Here

Medical records document the prescriber's decision to change medications, but pharmacy records document when the patient actually obtained the new medication. The fill date is the action date. If an MRI was performed on March 15 and the pharmacy record shows gabapentin first filled on March 17, that two-day gap confirms immediate clinical response to imaging findings. This timestamp precision is unique to pharmacy records.

Common Imaging-to-Prescription Patterns

MRI Reveals Disc Herniation: NSAID to Neuropathic Agent

The most frequent pattern in personal injury cases is the transition from a general anti-inflammatory regimen to a neuropathic pain regimen after MRI confirms disc herniation or nerve root compression. The pharmacy record will show discontinuation or dose reduction of the NSAID alongside initiation of gabapentin, pregabalin, or duloxetine -- medications specifically indicated for neuropathic pain conditions.

CT Reveals Fracture Complexity: Analgesic Escalation

When initial X-rays show a simple fracture but CT imaging reveals greater complexity -- comminution, articular involvement, or displacement -- the prescriber often escalates the pain management regimen. The pharmacy record captures this escalation as new fills for stronger analgesics or the addition of adjuvant pain medications.

MRI Reveals Soft Tissue Injury: Addition of Muscle Relaxants

Soft tissue injuries not visible on X-ray may be confirmed or characterized by MRI. When imaging reveals ligament tears, tendon injuries, or significant edema, prescribers frequently add muscle relaxants or modify the existing regimen. The fill date for the new muscle relaxant, correlated with the MRI date, documents this clinical response.

Building This Evidence for Demand Packages

The imaging-to-prescription link should be presented as a clear timeline in every demand package:

1. Accident date and initial prescription regimen -- what the plaintiff was first prescribed and when
2. Imaging date and findings -- when diagnostic imaging was performed and what it revealed
3. Post-imaging prescription change -- the new medication, its first fill date, and the number of days between imaging and the new fill
4. Clinical indication -- explicitly connecting the imaging finding to the medication change (e.g., "Gabapentin initiated for neuropathic pain secondary to L4-L5 disc herniation identified on MRI")
5. Continuation pattern -- showing that the post-imaging medication continued through the claim period

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes chronological medication changes correlated with clinical events including imaging studies.

Defeating Defense Arguments

"The imaging findings are degenerative, not traumatic."

Even if imaging shows some degenerative changes, the prescription change after imaging is still causation evidence. The plaintiff was not taking neuropathic pain medication before the accident. The accident caused symptoms. Imaging was ordered because of those symptoms. The prescriber reviewed the imaging and changed the medication. Whether the underlying finding is purely traumatic or an aggravation of a degenerative condition, the medication change documents that the accident made the condition symptomatic enough to require targeted pharmacological treatment.

"The medication change was unrelated to imaging."

This argument is difficult to sustain when pharmacy records show that the new prescription was filled within days of the imaging study. The temporal proximity, combined with the clinical appropriateness of the medication for the imaging finding, creates an inference that defense counsel must overcome with affirmative evidence -- not mere speculation.

Correlating Multiple Imaging Events

In complex cases, multiple imaging studies may trigger multiple medication changes over the course of treatment. A plaintiff may have an initial X-ray (leading to NSAIDs), an MRI at six weeks (leading to gabapentin), and a follow-up MRI at six months (leading to dose escalation or medication addition). Each imaging-to-prescription link reinforces the causation chain and documents the progression of injury.

Practical Takeaways

The imaging-to-prescription link is clinical causation documented in real time by pharmacy information systems. Attorneys who present this evidence transform abstract imaging findings into concrete treatment consequences -- demonstrating not just that pathology exists, but that it required specific pharmacological intervention that the plaintiff did not need before the accident. Every case with imaging-triggered medication changes contains this evidence. The question is whether counsel recognizes and presents it.

Related Resources

• What Is a MERIT Report? -- Understanding the pharmacist-authored clinical summary
• Medication Switches Prove Treatment Failure -- Using medication changes as evidence of treatment complexity
• Demand Package Pharmacy Records -- Integrating pharmacy documentation into demand letters